These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 21511556)
1. Internal jugular vein thrombosis by protein C activated resistance. Mnejja M; Hammami B; Bougacha L; Jemal L; Chakroun N; Chakroun A; Charfeddine I; Ghorbel A Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):269-71. PubMed ID: 21511556 [TBL] [Abstract][Full Text] [Related]
2. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis. Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165 [TBL] [Abstract][Full Text] [Related]
3. [Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis]. Jastrzebska M; Bałszan-Kowalska I; Ciechanowicz A; Bińczak-Kuleta A; Falkowski A; Chełstowski K Pol Arch Med Wewn; 2003 Jun; 109(6):579-88. PubMed ID: 14567090 [TBL] [Abstract][Full Text] [Related]
4. Resistance to activated protein C--frequent etiologic factor for venous thrombosis. Simkova M; Simko F; Kovacs L Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376 [TBL] [Abstract][Full Text] [Related]
5. [Internal jugular vein thrombosis in a patient with ovarian hyperstimulation syndrome]. el Haddad R; Kaprál A; Zivný J Ceska Gynekol; 2003 Mar; 68(2):114-7. PubMed ID: 12749181 [TBL] [Abstract][Full Text] [Related]
6. Sudden hearing loss followed by deep vein thrombosis and pulmonary embolism in a patient with factor V Leiden mutation. Lovato A; Tormene D; Staffieri C; Breda S; Staffieri A; Marioni G Int J Audiol; 2014 Sep; 53(9):625-8. PubMed ID: 24735015 [TBL] [Abstract][Full Text] [Related]
7. Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis. Lamparello BM; Erickson CR; Kulthia A; Virparia V; Thet Z Vasc Health Risk Manag; 2014; 10():609-13. PubMed ID: 25395858 [TBL] [Abstract][Full Text] [Related]
8. [Activated protein C resistance and deep venous thrombosis in pregnancy]. Procházka M; Krcová V; Hrachovec P; Kudela M; Slavík L Ceska Gynekol; 2002 Sep; 67(5):251-4. PubMed ID: 12434659 [TBL] [Abstract][Full Text] [Related]
9. Internal jugular vein thrombosis in association with the factor V Leiden mutation. Arullendran P; Jani P; Baglin T; Moffat DA J Laryngol Otol; 1998 Apr; 112(4):383-6. PubMed ID: 9659505 [TBL] [Abstract][Full Text] [Related]
10. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population. Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913 [TBL] [Abstract][Full Text] [Related]
11. Deep vein thrombosis followed by internal jugular vein thrombosis as a complication of in vitro fertilization in a woman heterozygous for the prothrombin 3' UTR and factor V Leiden mutations. McGowan BM; Kay LA; Perry DJ Am J Hematol; 2003 Aug; 73(4):276-8. PubMed ID: 12879433 [TBL] [Abstract][Full Text] [Related]
13. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism. Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075 [TBL] [Abstract][Full Text] [Related]
14. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA. Schöni R; Quehenberger P; Wu JR; Wilmer M Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy]. Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280 [TBL] [Abstract][Full Text] [Related]
17. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677 [TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis. Legnani C; Cini M; Cosmi B; Mattarozzi S; Lo Manto G; Palareti G Thromb Haemost; 2004 Apr; 91(4):712-8. PubMed ID: 15045132 [TBL] [Abstract][Full Text] [Related]
19. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population]. Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227 [TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of thrombophilia based on coagulation and genetic studies]. Bałszan-Kowalska I Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]